Literature DB >> 29960282

Recommendations for the management of tuberculosis in children - KOMPASS TB. Part 1: Tuberculosis prevention.

Teresa Bielecka, Ewa Augustynowicz-Kopeć, Paweł Gonerko, Paweł Gruszczyński, Maria Korzeniewska-Koseła, Maria Krasińska, Katarzyna Krenke1, Joanna Lange, Anna Pankowska, Marek Popielarz, Andrzej Pustkowski, Joanna Stryczyńska-Kazubska, Zbigniew Doniec.   

Abstract

Since the second half of the 20th century the incidence of tuberculosis has been declining in Poland. Despite this, current epidemiological data still support the need for the continued mass BCG vaccination in Poland in the near future. Apart from the protection against severe hematogenous forms of tuberculosis, vaccination lowers the risk of infection with Mycobacterium tuberculosis. Primary and acquired immunodeficiency, including immunity disorders associated with an ongoing treatment, are contraindications to BCG vaccination. The most common adverse effects following BCG vaccination are reactions at the site of injection and in regional lymph nodes, which usually does not require treatment. Methods of tuberculosis prevention, particularly recommended in low-incidence countries, include: diagnostic investigations of patients who had contacts with pulmonary tuberculosis as well as an active detection and treatment of latent Mycobacterium tuberculosis infection. Latent tuberculosis infection can be identified on the basis of positive results of the tuberculin skin test or interferon-gamma release assays after the active disease has been ruled out. This condition does require prophylactic treatment.

Entities:  

Keywords:  BCG vaccination; latent tuberculosis infection; tuberculosis contact investigation

Mesh:

Substances:

Year:  2018        PMID: 29960282     DOI: 10.5603/ARM.2018.0023

Source DB:  PubMed          Journal:  Adv Respir Med        ISSN: 2451-4934


  2 in total

1.  Molecular methods in diagnostics of post-BCG vaccine adverse events.

Authors:  Sylwia Agata BrzeziŃska; Teresa Bielecka; Anna Zabost; Agnieszka GŁogowska; Monika KoziŃska; Ewa Augustynowicz-KopeĆ
Journal:  Cent Eur J Immunol       Date:  2020-07-27       Impact factor: 2.085

2.  QuantiFERON-TB Gold Plus Test in Diagnostics of Latent Tuberculosis Infection in Children Aged 1-14 in a Country with a Low Tuberculosis Incidence.

Authors:  Dagmara Borkowska-Tatar; Maria Krasińska; Ewa Augustynowicz-Kopeć
Journal:  Pol J Microbiol       Date:  2021-12-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.